Clinical Trials Browser

Phase 4 × pertuzumab × 1 year × Clear all

NCT07093931 2025-07-30

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms